LWM
AUPH icon

LJI Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

LJI Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,030
Closed -$234K – 154
2023
Q4 		$234K Sell
26,030
-12,000
-32% -$98.8K 0.06% 148
2023
Q3 		$295K Sell
38,030
-1,500
-4% -$14.7K 0.09% 125
2023
Q2 		$383K Sell
39,530
-2,000
-5% -$20.8K 0.11% 94
2023
Q1 		$455K Sell
41,530
-7,400
-15% -$65.2K 0.14% 78
2022
Q4 		$211K Buy
+48,930
New +$284K 0.07% 130

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LJI Wealth Management's AUPH Position: Q1 2024 in Review

LJI Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 26,030 shares — an estimated $234K sold.

LJI Wealth Management first reported a position in AUPH in Q4 2022 and held it in 5 quarters. The position peaked at $455K in Q1 2023. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • LJI Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • LJI Wealth Management sold 26,030 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $234K.
  • LJI Wealth Management first reported a position in Aurinia Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • LJI Wealth Management's Aurinia Pharmaceuticals position peaked at $455K in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on LJI Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.